<DOC>
	<DOCNO>NCT01369186</DOCNO>
	<brief_summary>Study Objective : To investigate potential drug-drug interaction ( pharmacokinetics pharmacodynamics ) morphine antiplatelet drug ( aspirin , clopidogrel , prasugrel , ticagrelor )</brief_summary>
	<brief_title>Drug Drug Interactions Aspirin P2Y12-inhibitors</brief_title>
	<detailed_description>Rationale : Opiates reduce intestinal resorption orally administer drug paracetamol . Because morphine often injected relieve pain patient myocardial infarction , particular interest morphine may decrease rate absorption antiplatelet drug . Results study provide essential information use morphine antiplatelet drug clinical practice , particular myocardial infarction .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<criteria>Healthy volunteer ≥ 18 year age No intake NSARs P2Y12inhibitors within 14 day study entry Written inform consent Known coagulation disorder Relevant impairment hepatic function ( elevated transaminase , ≥ 2 fold ) Relevant impairment renal function Infectious disease ( HIV , hepatitis B C ) Gestation lactation Clinically relevant abnormal laboratory value Use medication 2 week start study , may affect validity study General contraindication aspirin ( resp . clopidogrel , prasugrel , ticagrelor ) morphine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>